SurvivinT34A increases the therapeutic efficacy of arsenic trioxide in mouse hepatocellular carcinoma models. [electronic resource]
Producer: 20170324Description: 3283-3290 p. digitalISSN:- 1791-2431
- Animals
- Antineoplastic Agents -- administration & dosage
- Apoptosis
- Arsenic Trioxide
- Arsenicals -- administration & dosage
- Carcinoma, Hepatocellular -- drug therapy
- Drug Resistance, Neoplasm
- Female
- Inhibitor of Apoptosis Proteins -- genetics
- Liposomes
- Liver Neoplasms, Experimental -- drug therapy
- Membrane Potential, Mitochondrial -- drug effects
- Mice, Inbred C57BL
- Mutation, Missense
- Neoplasm Transplantation
- Oxides -- administration & dosage
- Reactive Oxygen Species -- metabolism
- Repressor Proteins -- genetics
- Survivin
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.